BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19951182)

  • 21. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.
    Kennedy RB; Ovsyannikova IG; Haralambieva IH; Lambert ND; Pankratz VS; Poland GA
    Hum Genet; 2014 Nov; 133(11):1407-17. PubMed ID: 25098560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    Ogawa T; Inoue T; Kasahara K; Konishi M; Mikasa K
    PLoS One; 2020; 15(3):e0230329. PubMed ID: 32208432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of rubella virus-specific cell-mediated immunity using IFN gamma-ELISpot.
    Allmendinger J; Paradies F; Kamprad M; Richter T; Pustowoit B; Liebert UG
    J Med Virol; 2010 Feb; 82(2):335-40. PubMed ID: 20029797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.
    Kakoulidou M; Ingelman-Sundberg H; Johansson E; Cagigi A; Farouk SE; Nilsson A; Johansen K
    Vaccine; 2013 Jan; 31(4):711-7. PubMed ID: 23174196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
    Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
    Crooke SN; Haralambieva IH; Grill DE; Ovsyannikova IG; Kennedy RB; Poland GA
    Vaccine; 2019 Jun; 37(29):3876-3882. PubMed ID: 31126859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity to rubella: an Italian retrospective cohort study.
    Bianchi FP; De Nitto S; Stefanizzi P; Larocca AMV; Germinario CA; Tafuri S
    BMC Public Health; 2019 Nov; 19(1):1490. PubMed ID: 31703651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
    Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
    Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J
    J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mumps, measles and rubella vaccination in children with PFAPA syndrome.
    Kraszewska-Głomba B; Matkowska-Kocjan A; Miśkiewicz K; Szymańska-Toczek Z; Wójcik M; Banyś D; Szenborn L
    Vaccine; 2016 Nov; 34(48):5903-5906. PubMed ID: 27997341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
    Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.
    Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S
    J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.
    White SJ; Haralambieva IH; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
    Hum Immunol; 2012 Jun; 73(6):636-40. PubMed ID: 22504412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential durability of immune responses to measles and mumps following MMR vaccination.
    Kennedy RB; Ovsyannikova IG; Thomas A; Larrabee BR; Rubin S; Poland GA
    Vaccine; 2019 Mar; 37(13):1775-1784. PubMed ID: 30797639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM; Nielsen K; Garakian A; Cherry JD
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
    Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Tissue Antigens; 2008 Sep; 72(3):211-20. PubMed ID: 18715339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
    Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
    Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
    Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.